Axcelis Updates and Increases Q4 2023 Guidance
Reaffirms Full Year 2023 Revenue Expectations Above $1.1 billion
BEVERLY, Mass., Jan. 16, 2024 /PRNewswire/ — Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today increased financial guidance for the fourth quarter of 2023 and reaffirmed its expectations for the full year. Based on preliminary fourth quarter financial results, the Company expects revenue for the fourth quarter of 2023 to be greater than $300 million, above the approximately $295 million prior guidance, and reaffirmed its expectation for full year 2023 revenue above $1.1 billion. Earnings per diluted share for the fourth quarter of 2023 are now forecasted to be greater than $2.05, above prior guidance of approximately $2.00.
Related news for (ACLS)
- Axcelis Announces Financial Results for Fourth Quarter and Full Year 2023
- Axcelis to Participate in the 26th Annual Needham Growth Conference
- AXCELIS KOREA AND COUNTRY MANAGER WIN TRADE AWARDS FROM THE REPUBLIC OF KOREA
- Axcelis Announces Shipments of Purion XE High Energy and Purion H High Current Implanters to DRAM Memory Chipmakers